资讯

The Lancet28 天
Neoadjuvant therapy in HER2-positive breast cancer and interim PET – Authors' reply
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. We appreciate the ...